A key element of the structural model of ABC-ATPases is the interaction of the two ABC domains. They complement each other's active sites in a way that the ABC signature motif (LSGGQ) of one subunit interacts with the ␥-phosphate of the ATP, bound at the Walker motifs of the opposite subunit. In the present study, the conserved glycines in the fourth position of the LSGGQ motifs of human MRP1 were substituted for aspartic acids (G771D and G1433D), the mutants were expressed in Sf9 insect cells, and the nucleotide-as well as the transported substrate-protein interactions were studied. We found that these transport-and ATPase-incompetent mutants showed no nucleotide trapping under any of the conditions examined. However, when measuring the effect of nucleotide and transported substrates on the vanadate-induced cleavage reactions, we found that the effect of substrates on the cleavage reactions was significantly different in the mutant MRP1 proteins than in the wild type. Although the transported substrates (e.g. etoposide ؉ oxidized glutathione) stimulated the formation of the posthydrolytic complex in the wild type, this reaction was inhibited in the signature mutants. Our study also revealed that a similar mutation in the ABC signature of either ABC unit resulted in the same effect. We suggest that the conserved glycine residues in both LSGGQ segments are part of the conformational network, which is responsible for the accelerated hydrolytic activity upon interaction of the protein with its transported substrates. This intramolecular communication between the substrate-binding site and the catalytic centers is assumed to be a general feature of the molecular mechanism of ABC transporters.
Overexpression of the human multidrug resistance-associated protein (ABCC1) MRP1, a member of the ATP-binding cassette (ABC) 1 family, has been suggested to be responsible for cancer drug resistance (1) . All of the proteins in this family consist of two kinds of major polypeptide regions: transmembrane domains, usually with six membrane-spanning helices, and conservative ABC units. The ABC units harbor two consensus polypeptide sequences, the so called Walker A and Walker B (2) , which are present in many ATP-binding and/or utilizing proteins. In addition, in all ABC transporters a short, highly conserved polypeptide motif, the signature region, is found between the two Walker motifs, which is diagnostic for the whole superfamily (3, 4) .
MRP1 carries out the ATP-dependent extrusion of structurally dissimilar anticancer drugs, and its basal ATPase activity is stimulated by the transported drug substrates (5) . On one hand, the sites interacting with the drug substrates are presumably harbored in the transmembrane domains (6 -8) ; however, recent data suggest that the intracellular linkers L0 and L1 may also play role in binding drug substrates (9, 10) . On the other hand, the ATP hydrolysis, which energizes the transport, takes place within the ABC domains. This presumes an intramolecular interaction between the two regions, which mediates the allosteric effect of the drugs on the ATP hydrolysis.
No high resolution three-dimensional structure is available as yet for any of the mammalian ABC transporters, but there are several bacterial structures determined. The structure of Rad50cd, a bacterial ABC-ABC ATPase, represents two functionally interacting ABC subunits, dimerizing in a head-to-tail orientation (11) . In this dimer, the two ABC domains complement each other's active sites, forming composite catalytic centers. According to the structure, the Walker A sequence of one subunit and the ABC signature motif of the opposite one are involved in the formation of an ATP-binding site, and the two ATP molecules are completely buried in the dimer interface.
Comparison of the structures of the ATP-free and ATP-bound Rad50cds revealed a nucleotide-mediated movement of the lobe including the LSGGQ motif toward the bound ATP molecule within the opposite subunit (11) . This movement, which might be a general feature in ABC proteins, may provide the structural requirement for the completion of the catalytic site. This conformational change may ensure the precise geometry of the active catalytic sites. Similar arrangement of the ABC ATPase catalytic sites has been found in the MsbA lipid A transporter of Vibrio cholera (12) and in the BtuCD ABC transporter of Escherichia coli (13) . However, in a recent review this arrangement has been challenged in the case of the MsbA transporter of V. cholera (14) .
Recently, in an elegant work, vanadate-induced cleavage of the bacterial MalFGK 2 homodimeric ABC transporter was used to demonstrate the molecular proximity of the two ABC units and supported the "composite active center model" of the ABC ATPases (15) . In an other study, cysteines were intro-duced into the signature and Walker A motifs of a Cys-less version of human MDR1, and the mutants were subjected to oxidative cross-linking. On the basis of the experiments, the authors concluded that the signature sequence of one ABC unit is adjacent to the Walker A motif of the opposing ABC (16) . Furthermore, they studied the effect of drug binding on crosslinking in the same experimental system (17) . Substrates stimulating the ATPase activity increased, whereas those that inhibit the ATPase activity decreased the rate of cross-linking. These results demonstrate that drug binding to the transmembrane domains can induce conformational changes within the ABC domains.
Similar to ATP hydrolysis, the rate of the posthydrolytic transition state formation ("nucleotide trapping") in ABC transporters is accelerated by the transported drug substrates (18, 19) . We have shown earlier that nucleotide trapping in MDR1 signature mutants was inhibited, instead of accelerated, in the presence of substrates, suggesting a miscommunication between the drug-binding site(s) and the catalytic domains in these mutants (20) . We hypothesized that the characteristic rotation of the ABC signature motif found in the Rad50cd is an element of the drug-induced allosteric control of MDR1-ATPase activity, too. This conformational change ensures the precise geometry of the active catalytic site(s) in the wild type protein but is not proper when a critical residue of either ABC signature motif is mutated.
The aim of the present study was to characterize the highly conserved ABC signature regions in the ABC units of MRP1. In the experiments reported here, we have examined the effects of substitution of a conservative amino acid in the ABC signature regions of both the N-terminal and the C-terminal half of MRP1. The conserved glycines in the fourth position of the signature motifs (LSGGQ) were substituted for aspartic acids (G771D and G1433D). We have expressed the wild type and mutant MRP1 proteins in the baculovirus-Sf9 insect cell expression system, and the nucleotide-and substrate-MRP1 interactions were studied. In our recent work we have identified three orthovanadate cleavage sites within MRP1 and found that the initial rate of cleavage reactions were influenced by the presence of nucleotides and by transported substrates (25) . Here, we utilized this experimental approach to elucidate the possible role of the conserved glycine residues of the ABC signature regions of MRP1 in the catalytic cycle.
EXPERIMENTAL PROCEDURES
Construction of the Recombinant Transfer Vectors-For cloning various cDNA constructs, the modified baculovirus transfer vector pAcUW21-L was used (20) . Mutagenesis was performed by overlap extension PCR (21) with pAcUW21-L-MRP1 as template. Sequencing was performed to confirm the mutations and to ensure that no additional mutations occurred.
Generation of Recombinant Baculoviruses-Recombinant baculoviruses were generated, and Sf9 (Spodoptera frugipedra ovarian) cells were infected and cultured as described by Bakos et al. (22) . Individual clones expressing a high level of the MRP1 variants were obtained by end point dilution and subsequent amplification. For functional characterization the virus-infected Sf9 cells were harvested, the membrane fractions were isolated, the membrane protein concentrations were determined as described earlier (22, 23) .
Photoaffinity Labeling by [␣- 32 P]8-Azido-ATP-This method has been described in detail (19) . In brief, isolated Sf9 cell membranes were incubated for 5 min at 37°C in the presence of 5 M final concentration of 8-azido-ATP (Sigma) containing 0.1 MBq of [␣-
32 P]8-azido-ATP (Affinity Labeling Technologies; 10.8 Ci/mmol), with or without trapping agent. The reaction was stopped by the addition of an ice-cold buffer containing 10 mM MgATP. The membranes were washed twice in the same buffer and then irradiated for 3 min with UV (max about 250 nm) at a distance of 3 cm at 4°C.
The labeled samples were run on 7.5% Laemmli-type SDS-containing gels, the proteins were electroblotted to polyvinylidene difluoride membranes, and the blots were dried and subjected to quantitative autoradiography in a PhosphorImager (Bio-Rad). The identity of the labeled bands was confirmed by immunostaining of the same blot with anti-MRP1 monoclonal antibody m6 (24) .
Vanadate-induced Photo-oxidative Cleavage-Vanadate-induced cleavage reaction was performed as described by Kern et al. (25) . Briefly, samples containing the isolated Sf9 cell membranes (20 g) expressing wild type MRP1 (or its signature mutants) were preincubated at 37°C for 5 min in the presence of 800 M sodium orthovanadate and in the presence or absence of transported substrates in the reaction buffer (50 mM MOPS-Tris, pH 7.4, 50 mM KCl, 10 mM MgCl 2 ). Various concentrations of MgATP were subsequently added to the samples (as indicated in the figures) in the final volume of 40 l, and the tubes were incubated at 37°C for 5 and 20 min for obtaining N-and C-terminal cleavage, respectively. After incubation the reaction mixture was immediately transferred to ice and placed under a 265-nm ultraviolet lamp at a distance of 5 cm. The samples were irradiated for 10 and 2 min for N-and C-terminal cleavage, respectively. After irradiation 10 l of sample buffer (50 mM Tris-PO 4 , pH 6.8, 2% SDS, 2% ␤-mercaptoethanol, 2 mM EDTA, 20% glycerol, 0.02% bromphenol blue) was added to the reaction mixture, and the samples were subjected to SDS-polyacrylamide gel electrophoresis and immunoblot analysis (23) . Detection of human MRP1 with m6 (mouse monoclonal antibody, 10,000ϫ diluted) anti-MRP monoclonal antibody was performed as described (24) . The second antibodies were obtained from Jackson Immunoresearch (anti-mouse, peroxidase-conjugated donkey IgG, 10,000ϫ diluted). Immunoreactive bands were visualized by ECL (Amersham Biosciences). The bands were quantified by densitometry on ChemiDoc XRS (Bio-Rad) using the Quantity One (Bio-Rad) software. The data were analyzed by the KaleidaGraph software package (Synergy Software).
RESULTS
We have recently reported the expression and the preliminary characterization of ABC signature mutants of human MRP1 (26) . In the transport-and ATPase-incompetent mutants the conserved glycines in the fourth position of the LSGGQ motifs were substituted with glutamic acids (G771D and G1433D). It was found that the specific MgATP binding was preserved, but the occluded nucleotide state ("vanadate trapping") could not be detected. We concluded that the conserved glycine residues in the fourth position of the LSGGQ motifs are essential in MRP1-related function, but the specific role of these residues could not be determined.
The motor domain of myosin was crystallized in the presence of different anions, like vanadate (27) , fluoro-aluminate (28, 29) , and beryllium fluoride (28) , and it was found that the different complexes stabilized by the different anions reflect various states of ATP hydrolysis. Therefore, we performed nucleotide trapping experiments using beryllium fluoride and AlF 4 as inhibitory anions to stabilize the trapped MgADP in the catalytic center after hydrolysis. In experiments documented in Fig. 1A , isolated Sf9 membrane containing the wild type MRP1 and its signature mutants were incubated at 37°C for 5 min, in the presence of AlF 4 as inhibitory anion, and 5 M [␣-
32 P]8-azido-ATP. Wild type MRP1 showed significant ADPtrapping ability in all cases, whereas radioactive signal was absent from control membranes prepared from cells expressing ␤-galactosidase. When LTC 4 , a substrate and stimulator of the MRP1 ATPase activity, was also included in the reaction mixture, it had a stimulatory effect on the nucleotide trapping of the wild type MRP1 (second lane). A similar stimulatory effect of etoposide (0.5 mM) ϩ GSSG (2 mM) was observed (third lane).
We have seen the same results in the presence of Vi or beryllium fluoride (not shown here).
The trapping ability of the G771D and G1433D mutants was investigated under the same conditions as the wild type. As shown in As we demonstrated recently, the vanadate-catalyzed photooxidative cleavage reaction is also suitable for studying the individual steps of the ATPase cycle and for characterizing MRP1 interactions with nucleotide and transported substrates (25) . We have shown that in the case of wild type MRP1, three cleavage sites can be identified, at which the initial rate of the vanadate-induced cleavage is sensitive to the nucleotide-MRP1 as well as to transported substrate-MRP1 interaction. We have mapped the approximate positions of the cleavage sites within the linear sequence of MRP1. Fig. 2 shows the membrane topology model and the domain arrangement of MRP1 (30) and the putative sites of the vanadate-induced photo-oxidative cleavage within the polypeptide chain. The positions of the mutations are also indicated in the figure. Table I . summarizes the molecular events detected by the vanadate-mediated photochemical cleavage reactions at different cleavage sites of MRP1 (25) .
The Sf9 membrane samples containing human MRP1 or its signature mutants were subjected to photo-oxidative cleavage reaction as described under "Experimental Procedures," and the cleavage products were analyzed by SDS-PAGE and subsequent immunoblotting. In the following experiments a monoclonal antibody, m6, recognizing an extreme C-terminal epitope (Ref. 24 ; the position of the m6 epitope is indicated in Fig. 2 ) was used for immunodetection. The cleavage found in the mutant variants was always compared with that of the wild type MRP1.
First, we analyzed the high molecular weight products of Vi-induced photocleavage performed in the presence of orthovanadate (800 M). The cleavage reactions were performed in the presence of various concentrations of MgATP (0 -500 M) at 37°C, and the cleavage products were analyzed by using 7.5% SDS-PAGE and immunoblotting. As shown in Fig. 3 , if Vi was absent no specific cleavage product appeared (Fig. 3A , lane 1, on each gel). If no nucleotide was present in the cleavage reaction of MRP1, a 95-kDa cleavage product (corresponding to cleavage at site I; see Fig. 2 ), well recognized by the C-terminal antibody, was apparent. However, when MgATP was included into the reaction mixture, the amount of the 95-kDa product was decreased in a concentration-dependent fashion. Upon increasing the MgATP concentration in the reaction mixture, a cleavage product with an apparent molecular mass of 85 kDa (corresponding to cleavage at site II; see Fig. 2 ) also appeared (Fig. 3A, top gel) .
Analysis of high molecular cleavage products of the signature mutants revealed that cleavage at site I is similar to that of the wild type (Fig. 3A, middle and bottom gels) . On the basis of the determination of the f95, the concentration-dependent inhibition of cleavage at site I was quantitatively evaluated by densitometry (Fig. 3B) . The apparent half-maximal effect was at 5.6 Ϯ 1.0 M MgATP in the case of the wild type MRP1. The half-maximal concentration of inhibition was 19.2 Ϯ 2.1 and 30.9 Ϯ 5.9 M MgATP for G771D and G1433D, respectively. The differences in the apparent half-maximal effect of MgATP inhibition may be explained by lower affinity of the mutants toward MgATP.
Only a low level of cleavage product of G771D and G1433D mutants, resulting in the 85-kDa product, was observed in the full concentration range (0 -500 M) examined, and the cleavage product appeared even in the absence of added nucleotide (Fig. 3A, middle and bottom gels) . This suggests that the signal of 85-kDa product triggered by the Vi-induced cleavage of the mutants is nonspecific, because it is not affected by increasing ATP concentration in the reaction mixture.
Next, we investigated the generation of the 25-kDa MRP1 cleavage product and the MgATP concentration dependence of cleavage at site III at 37°C. The reaction products were analyzed by immunoblotting from 15% SDS-PAGE gels, and the m6 monoclonal antibody was used for detection again.
As demonstrated earlier (25) , low concentration of MgATP (0.1 ⌴) results in cleavage at Site III in MRP1, and the yield of the cleavage product increases up to 1 M MgATP (see also Fig. 4A, top gel) . Thereafter the yield of cleavage decreases gradually as the concentration of MgATP is increased, and in the presence of 50 M MgATP practically no cleavage is detected (the cleavage was dependent on the presence of vanadate (see first lane). A similar complex nucleotide concentration dependence of the cleavage at site III was observed in the case of both mutants (Fig. 4A, middle and bottom gels) .
The quantitative evaluation of the 25-kDa product by densitometry in the Vi-induced cleavage reaction showed a biphasic effect of the nucleotide concentration (Fig. 4B ). This analysis also revealed certain differences in the bell-shaped nucleotide dependence of cleavage at site III in MRP1 as compared with its signature mutants. In wild type MRP1 the increase of yield was detected up to 1 M, which was followed by immediate decrease at higher MgATP concentrations (1-500 M) and complete disappearance of cleavage at 50 M. In the mutants, however, the amount of the cleavage products was the highest at 2 M and still present at 50 M MgATP. Deconvolution of the obtained bell-shaped curves revealed the following half-maximal concentration values: 0.10 Ϯ 0.01 and 4.68 Ϯ 0.44 M MgATP for the rising and declining parts of the curve, respectively, in case of the cleavage of the wild type MRP1; 0.37 Ϯ 0.07 and 8.95 Ϯ 0.81 M MgATP for the rising and for the declining parts of the curve, respectively, in the case of G771D; 0.41 Ϯ 0.07 and 10.15 Ϯ 0.96 M MgATP for the rising and for the declining parts of the curve, respectively, in the case of G1433D.
In the next set of experiments we investigated the effect of transported substrates on the vanadate-induced cleavage reactions, observed at various sites as described above. Two different substrates or substrate combinations, LTC 4 (0.8 M) and etoposide (0.5 mM) ϩ GSSG (2 mM) were used in these experiments. Figs. 5 and 6 show the effects of LTC 4 (0.8 M) and etoposide (0.5 mM) ϩ GSSG (2 mM) on the vanadateinduced cleavage reactions at the different cleavage sites. No effect of the transported substrates on the cleavage reactions at Site I, resulting in the 95-kDa fragment, could be observed either when the wild type MRP1 or when the signature mutants were subjected to the cleavage reaction. As we described earlier, the cleavage of MRP1 at Site II, resulting in the 85-kDa fragment, was greater in the presence of the substrates (25) . No cleavage of either signature mutant at Site II was observed when the reaction mixture contained transported substrates. Fig. 5 shows a representative point (50 M) of the ATP concentration range. As shown in Fig. 6A , the extent of cleavage of wild type MRP1 at Site III, generating the 25-kDa fragment, was decreased in the presence of the MRP1 substrates. This effect was strictly nucleotide-dependent, because no cleavage was observed if MgATP was omitted. Interestingly, the transported substrates had different impact on the extent of cleavage at Site III in the case of the signature mutants than in the case of wild type MRP1. LTC 4 had little, if any effect, whereas the etoposide ϩ GSSG combination triggered stimulation, instead of an inhibition, in the rate of cleavage at Site III. In Fig. 6A the representative concentration of 2 M ATP is shown in the wild type and the mutants, respectively, whereas in Fig. 6B , the amount of the f25 fragment is graphed at the whole concentration range on the basis of three independent experiments. The plots obtained by quantitative densitometry of the radiograms show biphasic, bell-shaped-like function of cleavage versus MgATP concentration, both in the absence and in the presence of either etoposide ϩ GSSG or LTC 4 . In the case of wild type MRP1 the declining part of the curve is shifted toward lower The data represent the average of at least three independent sets of experiments. The plot shows the extent of cleavage resulting fragment f95; the plotted values were calculated by subtracting the relative densities from 100. q shows WT MRP1, f shows G771D, and ࡗ shows G1433D. C, densitometric evaluation of fragment f85 generated by cleavage reactions shown on A. The data represent the averages of at least three independent sets of experiments. The data are expressed as relative density, with densities measured in the cleavage reaction in the presence of 500 M MgATP arbitrarily set to 100. q shows WT MRP1, f shows G771D, and ࡗ shows G1433D. 
DISCUSSION
A general feature of ABC proteins is that they utilize the energy of MgATP binding and hydrolysis for conformational motion. In ABC transporters, in which the catalytic ABC domains are attached to membrane-spanning transmembrane domains, the conformational transitions result in the transport of substrates across biological membranes (31) .
The ABC domains consist of conserved sequence motifs, like the Walker A and Walker B motifs, the so called "Q-loop," the "His switch," and the ABC signature sequence, which is diagnostic to the ABC proteins (3, 4) . The ATP hydrolytic sites (catalytic sites) at the dimer interface are completely buried, and the two ABC domains function in tight interaction. They complement each other's active sites in a way that two highly conserved residues of the ABC signature motif (LSGGQ), a serine in the second position and a glycine in the fourth position, of one subunit interact with the oxygen of the ␥-phosphate of the ATP bound at the Walker motifs of the opposite subunit (11) . Comparison of the ATP-free and ATP-bound structures revealed that a helix, which is directly connected to the LSGGQ segment, makes a rotation resulting in the displacement of the ATP-interacting residues of the LSGGQ motif toward the bound ATP molecule within the opposite subunit. This move- ment may provide the structural requirement for the completion of the catalytic sites.
We have recently reported the expression and the preliminary characterization of four ABC signature mutants of human MRP1 (26) . These mutations affect the conserved LSGGQ motifs in either ABC domain; the leucines were replaced with arginines (L768R and L1430R), and the glycines in position 4 were substituted with glutamic acids (G771D and G1433D). It was found that the mutants could be expressed in Sf9 insect cells as effectively as the wild type MRP1, and the Leu 3 Arg replacements do not effect the drug-stimulated ATPase activity or the ATP-dependent LTC 4 transport activity of the MRP1-variants. The Gly 3 Asp replacements resulted in complete loss of both the ATPase and the transport activities. Specific MgATP binding of the Gly 3 Asp mutants was preserved, but the occluded nucleotide state (nucleotide trapping) in the presence of vanadate could not be observed. It was concluded that the conserved glycine residues in the fourth position of the LSGGQ motifs are essential in MRP1-related function. 2 It is worthwhile to note that the conservation of the glycine residue in the fourth position of the ABC signature region is universal in the ABC family and that the MRP1 G771D mutation is analogous to a disease-causing mutation in (G551D), which is associated with a severe form of cystic fibrosis.
To better understand the specific role of the conserved glycine 2 While this article was in press, a paper about the functional consequences of the glycine 3 glutamic acid replacements in the LSGGQ motifs of MRP1 has been published (32) . In harmony with our recent study (26) , the authors also found that these glycines are essential for function but could detect a slight labeling after azido trapping in the presence of vanadate in one of the mutants. However, there is a notable difference between the expressed proteins they used as compared with those of the present study; here we performed all of the experiments using a full-length single chain MRP1, whereas Ren et al. (32) utilized an experimental system in which the N-and C-terminal halves of MRP1 have been coexpressed. residues, in the present work first we asked whether beryllium fluoride or fluoro-aluminate as inhibitory anions can stabilize the trapped MgADP in the catalytic centers of the Gly 3 Asp mutants. As is shown in Fig. 1 , neither G771D nor G1433D could perform nucleotide trapping irrespective of which inhibitory anion was present. No trapping was detected at higher Mg-azido-ATP concentrations, or when a transported substrates (LTC 4 or etoposide ϩ GSSG) were present, whereas the presence of transported substrates accelerated the rate of formation of the trapped nucleotide complex in wild type MRP1. These data indicate that in the G771D and G1433D signature mutants the MRP1*-MgADP*anion transition state-like complex formation cannot be detected by azido-ATP labeling.
Next, we utilized a different experimental strategy to elucidate the role of these residues in the catalytic/transport cycle of MRP1. As we demonstrated recently, the vanadate-catalyzed photo-oxidative cleavage reaction is suitable for studying individual steps of the ATPase cycle and for characterizing the nucleotide-MRP1 and transported substrate-MRP1 interactions (25) . We have shown that in the case of wild type MRP1 three cleavage sites can be identified (see Fig. 2 ), at which the initial rate of the vanadate-induced cleavage is sensitive to these interactions. We have demonstrated that the nucleotidedependent inhibition of cleavage at Site I is caused by specific nucleotide binding and/or by formation of a prehydrolytic complex, whereas the vanadate involved in cleaving MRP1 at site II resides in one of the active sites as part of the MRP1*MgADP*Vi transition state-like complex (trapped nucleotide) (25) . Cleavage reaction at Site III is modulated by prehydrolytic events (nucleotide binding and prehydrolytic complex formation). The biphasic nature of the nucleotide concentration dependence of the cleavage reaction at Site III was interpreted to mean that the nucleotide-MRP1 interaction at the site that controls vanadate-induced cleavage at Site I has a major impact on the nucleotide binding properties detected at Site III, namely that it accelerates the conversion of the bound nucleotide state to a prehydrolytic intermediate state (25) . Two of the three cleavage sites are present in the MRP1 signature mutants too, although differences in the concentration dependence of the cleavage reactions were detected.
Our result that cleavage of the signature mutants at Site I is preserved (Fig. 3A) is in harmony with the conclusion that these ATPase-and transport-defective signature mutants are capable of normal ATP binding, as it was revealed by azido-ATP photo cross-linking studies, too (26) . The differences in the apparent half-maximal effect of MgATP inhibition on cleavage at site I (5.6 Ϯ 1.0 M MgATP in case of wild type versus 19.2 Ϯ 2.1 and 30.9 Ϯ 5.9 M MgATP, for G771D and G1433D, respectively) may be explained by the lower affinity of the mutants toward MgATP (Fig. 3B) .
The lack of specific nucleotide-dependent cleavage of the signature mutants at site II (Fig. 3A) indicates that the transition state-like complex formation cannot be detected in these mutants. This observation is in line with the similar finding that the occluded nucleotide state (nucleotide trapping) in the presence of vanadate could not be observed in these mutants by azido-ATP photolabeling (26) .
Similarly to the wild type MRP1, a complex nucleotide concentration dependence of the cleavage at site III was observed in the case of both mutants (Fig. 4A) . The quantitative evaluation of the product generated by cleavage at Site III revealed a biphasic function of the nucleotide concentration in each case (Fig. 4B) , although certain differences in the bell-shaped nucleotide dependence of cleavage at site III in MRP1 as compared with its signature mutants were determined. As we described earlier the yields of cleavage reactions at both Site I and Site III are modulated by prehydrolytic events (25) . Consequently, the effect of nucleotides on the cleavage at Sites I and III comes from the conformational changes induced by these prehydrolytic events, and these conformational transitions are preserved in the MRP1 signature mutants.
It is well established that the interaction of transported substrates with MRP1 accelerates the initial rate of ATP hydrolysis ("drug-stimulated ATPase activity") and that formation of the MRP1*MgADP*anion transition state-like intermediate is also facilitated in the presence of transported substrates (Fig. 1) . The rate of vanadate-induced cleavage of MRP1 is also influenced if the reaction mixture contains transported substrates (25) . It is important to state that the experimental approach based on vanadate-mediated cleavage reactions, similar to nucleotide-trapping, is able to detect interaction of transported substrates with the transporter (i.e. binding) but not the transport itself, because the cleavage per se interrupts the catalytic/transport cycle. Here we investigated how the transported substrates modulate the nucleotidedependent vanadate cleavage reactions of the MRP1 signature mutants. Two different substrates or substrate combinations, LTC 4 (0.8 M) and etoposide (0.5 mM) ϩ GSSG (2 mM), were used. The lack of effect of the transported substrates on the cleavage reactions at Site I, resulting in the 95-kDa fragment when either the wild type MRP1 or when the signature mutants were subjected to the cleavage reaction (Fig. 5) , led to the conclusion that interaction of the substrate with the transporter does not modulate the nucleotide-MRP1 interaction detected by cleavage at Site I. Cleavage at Site II reflects the formation of the MRP1*MgADP*Vi transition state-like complex (trapped nucleotide) (25) . Substrates thus facilitate the vanadate-induced cleavage at this site in the wild type MRP1 (see the amount of the 85-kDa fragment in Fig. 5 ). This effect could be observed only under hydrolytic conditions (at 37°C but not at 0°C). The signature mutants were not specifically cleaved at this site, not even in the presence of those substrate concentrations, which were effective in the case of the wild type transporter (Fig. 5) . These results further support the conclusion that the signature mutants are not able to form the MRP1*MgADP*Vi transition state-like complex, which is detected by cleavage at Site II.
The extent of cleavage of MRP1 at Site III, generating the 25-kDa fragment, was decreased in the presence of the MRP1 substrates (Ref. 25 ; see also Fig. 6A, top gel) , as the declining part of the concentration curve is shifted toward the lower MgATP concentrations (Fig. 6B, top curves) . Because we interpreted the declining part of the curve as conversion of the bound nucleotide state to a prehydrolytic state (see above), the left shift in this phase in the presence of transported substrates, which could be detected only under hydrolytic conditions, detects the conversion of the prehydrolytic complex to the posthydrolytic enzyme*MgADP*Vi complex. It was concluded that this reaction is the target of substrate-induced allosteric effect, which can be detected as Site III cleavage (25) . In other words, the intermolecular communication between the substrate-interacting site(s) and the catalytic site(s) is demonstrated here. The transported substrates had a paradoxical effect on the nucleotide-dependent cleavage of the signature mutants at Site III (Fig. 6A, middle and bottom gels) . As shown in Fig. 6B , in the presence of LTC 4 the characteristic left shift of the biphasic curve could not be detected in the case of either mutant. When the substrate combination of etoposide ϩ GSSG was present during the cleavage reactions, the declining part of the concentration curve shifted toward the higher, instead of the lower, concentrations in the case of both mutants. Similar to the wild type, this shift was observable only if the cleavage reactions were performed under hydrolytic conditions. These results indicated that the signature mutants are capable of performing a posthydrolytic reaction, but the substrate-mediated allosteric control of this posthydrolytic reaction is jeopardized by the glycine-glutamic acid replacement in either ABC domain.
The lack of a concentration shift in the present of LTC 4 might be interpreted to mean that there is no posthydrolytic complex formation in either mutant. However, the effect of etoposide ϩ GSSG argues against this interpretation and supports the conclusion that a miscommunication between the drug-binding site(s) and the catalytic apparatus is apparent in the ABC signature mutants. This means that the conserved glycine residues in the fourth position of the ABC signature regions are involved in the intramolecular communication from the substrate-binding site toward the catalytic site. One possible explanation is that the characteristic rotation of the LSGGQ motif is an element of the substrate-mediated allosteric control of the MRP1-ATPase activity. The resulting conformational change ensures the required geometry of the composite catalytic site(s), but the effective interaction with the ATP and the substrate is missing when the crucial glycine is mutated to glutamic acid.
Collectively, our results revealed that the conserved glycines are not essential in nucleotide binding or in the nucleotidemodulated interaction between the two nucleotide-binding sites. However, they play an essential role in posthydrolytic complex formation, and they are part of the conformational network, which is responsible for the accelerated hydrolytic activity upon interaction of the transporter with its transported substrates. Our study also revealed that similar mutation in the ABC signature of either ABC unit of MRP1 resulted in the same effect on the transmission of conformational change in the substrate-binding site to the catalytic domains.
A similar conclusion had been obtained about the role of the conserved glycine of the ABC signature regions in the intramolecular communication, when the analogous glycine residues of human MDR1 were replaced with glutamic acids (20) . In these MDR1 mutants the trapped nucleotide complex could be analyzed by azido-ATP labeling, and it was shown that the interaction of transported substrates with the mutant transporters inhibited rather than accelerated the rate of formation of this intermediate. Furthermore, utilizing Cys-Cys oxidative crosslinking, it was found that binding of the drug substrates to MDR1 triggers a conformational change that decreases the distance between the LSGGQ segment and the Walker A motif (17) , thus providing the structural basis of a more efficient catalysis.
Based on these data we suggest that the conserved glycine in the LSGGQ segments is part of an intramolecular communication system between the substrate-binding site and the catalytic centers within both MRP1 and MDR1 transporters, and this may be a general element of the molecular mechanism of the ABC transporters.
